betamethasone-17,21-dipropionate has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, G; Bouchaud, G; Boumendjel, A; Boyère, C; Dumontet, C; Esmenjaud, J; Gardebien, F; Haudecoeur, R; Magnan, A; Matera, EL; Mathé, D; Mattei, E; Monneret, G; Nurisso, A; Pérès, B; Peuchmaur, M; Tourette, A | 1 |
2 other study(ies) available for betamethasone-17,21-dipropionate and Asthma
| Article | Year |
|---|---|
Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.
Topics: Animals; Asthma; Basophils; Cell Degranulation; Chalcones; Dermatitis, Atopic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Mice; Models, Molecular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors | 2018 |
[Corticoid therapy in asthma. Smaller particles--bigger effect].
Topics: Aerosol Propellants; Anti-Asthmatic Agents; Asthma; Betamethasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Particle Size; Solutions | 2004 |